DebraLynnSimmonsMD
Endocrinology • Salt Lake City, UTDiabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology
Assistant Professor of Medicine, University Ark
Dr. Simmons is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
615 S Arapeen Dr
Ste 100
Salt Lake City, UT 84108Phone+1 801-587-3926Fax+1 801-587-3920
Education & Training
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1986 - 1988
Indiana University School of MedicineResidency, Internal Medicine, 1982 - 1985
University of Texas Southwestern Medical SchoolClass of 1982
Certifications & Licensure
UT State Medical License 2012 - 2024
AR State Medical License 1997 - 2023
CA State Medical License 1985 - 2022
TX State Medical License 1983 - 2022- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 5 citationsInsulin use in chronic kidney disease and the risk of hypoglycemic events.Daulton Grube, Guo Wei, Robert Boucher, Nikita Abraham, Na Zhou
BMC Nephrology. 2022-02-21 - 3 citationsCombined Medicine-Pediatrics Fellowships: A Guide for Fellowship Directors and Residents.Burton Shen, Janaki D. Vakharia, Lisa Swartz Topor, Brett W. Robbins, Kathryn Diamond-Falk
Cureus. 2021-06-16 - 1 citationsThe Role of Advocacy in Adapting the Diabetes Prevention Program for Couple-Based Delivery That Reaches Marginalized Groups.Aguirre Mc, Brown H, Gershenoff D, Hinton Kl, Huntzinger Om
The Behavior Therapist. 2020-10-01
Press Mentions
Experimental Drug Could Be New Option for Type 2 DiabetesJanuary 18th, 2019
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
